Looking to expand your partner network with leading companies like Institut Curie? Consider joining Inpart's global network for free.
News and Trends 7 Feb 2023
Mnemo Therapeutics and Institut Curie studies lead to cancer-specific targets
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies developed at Institut Curie, its closest academic collaborator, in the journal Science Immunology. The publications reveal TE-exon splicing junctions act as a source of novel recurrent, cancer-specific targets and have potential implications for developing more effective and less toxic immunotherapies. […]